Oncotelic Therapeutics's total assets for Q4 2025 were $10.00T>, an increase of 1396100078.85% from the previous quarter. OTLC total liabilities were $10.00T> for the fiscal quarter, a 654177626.99% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.